TLDR
- Wellgistics Health stock jumped 135% on Friday in a delayed reaction to a Wednesday announcement about partnering with AI data company DataVault.
- The companies signed a non-binding letter of intent to create blockchain-enabled smart contracts using Wellgistics’ PharmacyChain technology for tracking prescription drugs from script to fulfillment.
- Trading volume exploded to over 167 million shares compared to the typical daily average of 1.11 million shares.
- Despite Friday’s rally, WGRX stock remains down 86.7% year-to-date and has struggled with losses of $6.67M in the most recent quarter.
- The stock trades at penny stock levels with high volatility, making it a risky bet for most investors.
Wellgistics Health stock experienced a massive rally on Friday morning, climbing 135% in pre-market trading. The pharmaceutical company’s shares had been up 9.04% on Thursday before the bigger move hit.
Wellgistics Health, Inc., WGRX
The surge came two days after Wellgistics announced a partnership with DataVault, an AI data company. Retail traders appeared to discover the news with a delay, triggering the late price reaction.
The two companies signed a non-binding letter of intent to develop manufacturer-to-patient blockchain-enabled smart contracts. The system will use Wellgistics’ proprietary PharmacyChain technology and existing physical infrastructure.
The partnership aims to enable full digital tracking of prescription drugs from initial prescription to final fulfillment. Both companies plan to share revenue generated from fees collected through this tracking system.
Prashant Patel, President and interim CEO of Wellgistics Health, explained the reasoning behind the deal. He stated that reducing administrative burden through blockchain-enabled smart contracts represents a logical next step for helping pharmacists ensure patients receive medications on time and within budget.
Trading Volume Spikes
The Friday rally brought exceptional trading activity to WGRX. More than 167 million shares changed hands during the session.
That volume dwarfs the company’s typical daily average of 1.11 million shares. The massive spike indicates retail trader interest flooded into the stock.
DataVault stock also benefited from the announcement, rising 24.89%. The partnership appears to have caught trader attention across both companies.
Financial Picture Remains Challenging
Despite Friday’s dramatic price movement, Wellgistics faces financial headwinds. The stock has fallen 86.7% year-to-date and over the past 12 months.
Recent quarterly results showed net income losses of $6.67M. Revenue came in at $18.13M for the period.
The company carries an enterprise value of $58.31M. Total operating expenses reached $13.29M in the most recent quarter.
Wellgistics trades with a price-to-book ratio of 34.31. The return on equity ratio sits above 1856.21, reflecting volatile market valuations.
The stock trades at penny stock price levels. This classification typically indicates higher risk and volatility.
Prior to Friday’s surge, shares were trading around $0.80 before jumping to $1.31. The price movement represents the kind of wild swings common in lower-priced stocks.
Analysts caution that the delayed reaction to Wednesday’s news and the penny stock status make WGRX a volatile play. The stock’s history of steep declines over the past year adds to the risk profile.
The company continues working to expand its distribution network and product lineup. Management hopes these efforts will help capture a larger share of the healthcare distribution market.

